Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2-Reference-Cited by-同舟云学术

Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2

Published:2009-08-05 Issue:6 Volume:50 Page:1861-1870
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Blechacz Boris R. A.,Smoot Rory L.,Bronk Steven F.,Werneburg Nathan W.,Sirica Alphonse E.,Gores Gregory J.

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.23214/fullpdf

Reference39 articles.

1. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment;Blechacz;HEPATOLOGY,2008

2. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis;Bollrath;Cancer Cell,2009

3. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer;Grivennikov;Cancer Cell,2009

4. The STATs of cancer-new molecular targets come of age;Yu;Nat Rev Cancer,2004

5. Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution;Aggarwal;Ann N Y Acad Sci,2006

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tyrosine phosphatase PTPN11/SHP2 in solid tumors - bull’s eye for targeted therapy?;Frontiers in Immunology;2024-03-05

2. Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy;MedComm;2024-02

3. Mechanistic Insights about Sorafenib-, Valproic Acid- and Metformin-Induced Cell Death in Hepatocellular Carcinoma;International Journal of Molecular Sciences;2024-02-01

4. PRECLINICAL MODELS OF LIVER CÂNCER;Arquivos de Gastroenterologia;2023-09

5. Discovery of STAT3 Inhibitors: Recent Advances and Future Perspectives;Current Medicinal Chemistry;2023-05